Research article · 15 Apr 2026
CommentaryPublished 22 Apr 2020
Increased Neutrophil to Lymphocyte Ratio (NLR) is a Sign of Disease Activity in Systemic Lupus Erythematosus Patients with Renal Involvement
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Systemic lupus erythematosus (SLE) is an idiopathic multi-systemic autoimmune disease that covers a wide array of clinical and laboratory findings. Neutrophil to lymphocyte ratio (NLR) is a simple onsite available recently emerged inflammatory marker which is evaluated in different inflammatory conditions such as infection, athero-embolic disease, malignancies and autoimmune disease. In this study we aimed to investigate any relation between disease activity and NLR of the SLE patients with renal involvement. In this study we retrospectively analyzed hematological and laboratory parameters of SLE patients with renal involvement during both in active disease and in remission period. We investigated 36 SLE patients with renal involvement in their active and remission period of the disease. Mean proteinuria and serum albumin level of the patients at active disease period were 5.26 ± 2.92 gr/day, 2.58 ± 0.71 gr/dl in orderly. Mean proteinuria and serum albumin level of the patients at remission period after cessation of intensive immunosuppression were 0.77 ± 1.59 gr/day, 4.08 ± 0.58 gr/dl inorderly. Mean NLR at active disease period of the patients was statistically significantly detected higher than at remission period (6.11 ± 5.89, 2.65 ± 1.53, p=0.00). We detected that SLE patients with renal involvement has a high NLR during disease activation and statistically significantly lower NLR at remission period. We offer to investigate NLR as a disease activity marker for SLE patients with renal involvement via prospective randomized large scaled studies.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Nurhan Bilen”
- BylineArticles whose byline prints “Erdem Cankaya”
- BylineArticles whose byline prints “Yusuf Bilen”
- BylineArticles whose byline prints “Abdullah Uyanik”
- BylineArticles whose byline prints “Fuat Erdem”
